Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Robin M Nance

Biographic Data

ID7447634
NAMERobin M Nance
GIVEN NAMESRobin M
FAMILY NAMENance
SIGNATURENANCE R M
AFFILIATIONSUniversity of Washington
ORCID0000-0002-4412-4844
VERIFIEDYes
TOTAL WORKS17
TOTAL CITATIONS0
AUTHOR COUNT17
EDITOR COUNT0
FIRST PUBLICATION YEAR2016
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Barriers to accessing medications for opioid use disorder among rural individuals

    Open Access•Anna M Morenz, Robin M Nance et al.•ARTICLE•International Journal of Drug…•2025

    Access barriers vary by MOUD type for rural individuals with OUD. Compared to sublingual buprenorphine, methadone access was hindered more by transportation difficulties, while injectable long-acting buprenorphine was hindered more by affordability and finding a doctor or program. These barriers highlight the need to de-regulate and expand locations for methadone access and prescribing, and to improve affordability and prescriber uptake of newer …

  • Correlates of Intimate Partner Violence, Including Psychological Partner Violence, in a Multisite U.S. Cohort of People in HIV Care

    Open Access•Rob Jay Fredericksen, L S Mixson et al.•ARTICLE•AIDS and Behavior•2024

  • Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era

    Jimmy Ma, Betty Luu et al.•ARTICLE•AIDS Care•2024

    Substance use in people with HIV (PWH) negatively impacts antiretroviral therapy (ART) adherence. However, less is known about this in the current treatment era and the impact of specific substances or severity of substance use. We examined the associations of alcohol, marijuana, and illicit drug use (methamphetamine/crystal, cocaine/crack, illicit opioids/heroin) and their severity of use with adherence using multivariable linear regression in a…

  • Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time among People with HIV in the Current Treatment Era

    Open Access•Jimmy Ma, Joseph Delaney et al.•ARTICLE•AIDS and Behavior•2024

  • Vaporized nicotine use among patients in HIV care who smoke tobacco

    Rob Jay Fredericksen, Emma Fitzsimmons et al.•ARTICLE•AIDS Care•2023

    Evidence suggests adverse health effects from vaporized nicotine (VN) use, such as electronic “e” cigarettes, and limited efficacy to aid tobacco cessation. People with HIV (PWH) smoke tobacco at higher rates than the general population, with greater morbidity, highlighting the necessity of effective tobacco cessation tools. PWH may be more vulnerable to adverse effects of VN. Using semi-structured 1:1 interviews, we examined health beliefs regar…

  • Clinical and Behavioral Outcomes for Transgender Women Engaged in HIV Care

    Open Access•Sari L Reisner, Bridget M Whitney et al.•ARTICLE•AIDS and Behavior•2023

  • Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas

    Open Access•Umed Ibragimov, Melvin D Livingston et al.•ARTICLE•AIDS and Behavior•2023

  • Drug and alcohol use among people living with HIV in care in the United States by geographic region

    Heidi M Crane, Robin M Nance et al.•ARTICLE•AIDS Care•2021

    Substance use in the U.S. varies by geographic region. Opioid prescribing practices and marijuana, heroin, and methamphetamine availability are evolving differently across regions. We examined self-reported substance use among people living with HIV (PLWH) in care at seven sites from 2017-2019 to understand current regional substance use patterns. We calculated the percentage and standardized percentage of PLWH reporting current drug use and at-r…

  • Patient acceptability and usability of a self-administered electronic patient-reported outcome assessment in HIV care

    Rob Jay Fredericksen, Barbara N Harding et al.•ARTICLE•AIDS Care•2021

    We assessed acceptability/usability of tablet-based patient-reported outcome (PRO) assessments among patients in HIV care, and relationships with health outcomes using a modified Acceptability E-Scale (AES) within a self-administered PRO assessment. Using multivariable linear regression, we measured associations between patient characteristics and continuous combined AES score. Among 786 patients (median age=48; 91% male; 49% white; 17% Spanish-s…

  • Impact and correlates of sub-optimal social support among patients in HIV care

    Rob Jay Fredericksen, Laura E Gibbons et al.•ARTICLE•AIDS Care•2021

    Social support (SS) predicts health outcomes among patients living with HIV. We administered a brief, validated measure of SS, the Multifactoral Assessment of Perceived Social Support, within a patient-reported outcomes assessment of health domains in HIV care at 4 U.S. clinics in English and Spanish (n = 708). In univariate analysis, low SS was associated with poorer engagement in care, antiretroviral adherence, and health-related quality of lif…

  • Correlates of psychological intimate partner violence with HIV care outcomes on patients in HIV care

    Open Access•Rob Jay Fredericksen, Robin M Nance et al.•ARTICLE•BMC Public Health•2021

    Psychological IPV, even in the absence of physical or sexual IPV, appears to be associated with HIV care outcomes and should be included in IPV measures integrated into routine HIV care

  • Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United States

    Open Access•Catherine R Lesko, Robin M Nance et al.•ARTICLE•AIDS and Behavior•2020

  • Co-calibration of two self-reported measures of adherence to antiretroviral therapy

    Robin M Nance, Joseph Delaney et al.•ARTICLE•AIDS Care•2017

    Adherence to antiretroviral therapy (ART) is an important determinant of clinical success assessed in many HIV studies. Harmonizing adherence data from studies that use different measures is difficult without a co-calibration equation to convert between validated instruments. Our purpose was to co-calibrate two commonly used adherence measures: the AIDS Clinical Trials Group (ACTG) questionnaire and the Visual Analog Scale (VAS). We used robust l…

  • Not all non-drinkers with HIV are equal

    Heidi M Crane, Robin M Nance et al.•ARTICLE•AIDS Care•2017

    Studies of persons living with HIV (PLWH) have compared current non-drinkers to at-risk drinkers without differentiating whether current non-drinkers had a prior alcohol use disorder (AUD). The purpose of this study was to compare current non-drinkers with and without a prior AUD on demographic and clinical characteristics to understand the impact of combining them. We included data from six sites across the US from 1/2013 to 3/2015. Patients com…

  • HIV Provider Documentation and Actions Following Patient Reports of At-risk Behaviors and Conditions When Identified by a Web-Based Point-of-Care Assessment

    Open Access•Heidi M Crane, Paul K Crane et al.•ARTICLE•AIDS and Behavior•2017

  • Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

    Open Access•Heidi M Crane, Mary E McCaul et al.•ARTICLE•AIDS and Behavior•2017

  • A Comparison of Adherence Timeframes Using Missed Dose Items and Their Associations with Viral Load in Routine Clinical Care

    Open Access•Heidi M Crane, Robin M Nance et al.•ARTICLE•AIDS and Behavior•2016

No prominent works on this page.

  • A Comparison of Adherence Timeframes Using Missed Dose Items and Their Associations with Viral Load in Routine Clinical Care

    Open Access•Heidi M Crane, Robin M Nance et al.•ARTICLE•AIDS and Behavior•2016

  • Co-calibration of two self-reported measures of adherence to antiretroviral therapy

    Robin M Nance, Joseph Delaney et al.•ARTICLE•AIDS Care•2017

    Adherence to antiretroviral therapy (ART) is an important determinant of clinical success assessed in many HIV studies. Harmonizing adherence data from studies that use different measures is difficult without a co-calibration equation to convert between validated instruments. Our purpose was to co-calibrate two commonly used adherence measures: the AIDS Clinical Trials Group (ACTG) questionnaire and the Visual Analog Scale (VAS). We used robust l…

  • Not all non-drinkers with HIV are equal

    Heidi M Crane, Robin M Nance et al.•ARTICLE•AIDS Care•2017

    Studies of persons living with HIV (PLWH) have compared current non-drinkers to at-risk drinkers without differentiating whether current non-drinkers had a prior alcohol use disorder (AUD). The purpose of this study was to compare current non-drinkers with and without a prior AUD on demographic and clinical characteristics to understand the impact of combining them. We included data from six sites across the US from 1/2013 to 3/2015. Patients com…

  • HIV Provider Documentation and Actions Following Patient Reports of At-risk Behaviors and Conditions When Identified by a Web-Based Point-of-Care Assessment

    Open Access•Heidi M Crane, Paul K Crane et al.•ARTICLE•AIDS and Behavior•2017

  • Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

    Open Access•Heidi M Crane, Mary E McCaul et al.•ARTICLE•AIDS and Behavior•2017

  • Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United States

    Open Access•Catherine R Lesko, Robin M Nance et al.•ARTICLE•AIDS and Behavior•2020

  • Drug and alcohol use among people living with HIV in care in the United States by geographic region

    Heidi M Crane, Robin M Nance et al.•ARTICLE•AIDS Care•2021

    Substance use in the U.S. varies by geographic region. Opioid prescribing practices and marijuana, heroin, and methamphetamine availability are evolving differently across regions. We examined self-reported substance use among people living with HIV (PLWH) in care at seven sites from 2017-2019 to understand current regional substance use patterns. We calculated the percentage and standardized percentage of PLWH reporting current drug use and at-r…

  • Patient acceptability and usability of a self-administered electronic patient-reported outcome assessment in HIV care

    Rob Jay Fredericksen, Barbara N Harding et al.•ARTICLE•AIDS Care•2021

    We assessed acceptability/usability of tablet-based patient-reported outcome (PRO) assessments among patients in HIV care, and relationships with health outcomes using a modified Acceptability E-Scale (AES) within a self-administered PRO assessment. Using multivariable linear regression, we measured associations between patient characteristics and continuous combined AES score. Among 786 patients (median age=48; 91% male; 49% white; 17% Spanish-s…

  • Impact and correlates of sub-optimal social support among patients in HIV care

    Rob Jay Fredericksen, Laura E Gibbons et al.•ARTICLE•AIDS Care•2021

    Social support (SS) predicts health outcomes among patients living with HIV. We administered a brief, validated measure of SS, the Multifactoral Assessment of Perceived Social Support, within a patient-reported outcomes assessment of health domains in HIV care at 4 U.S. clinics in English and Spanish (n = 708). In univariate analysis, low SS was associated with poorer engagement in care, antiretroviral adherence, and health-related quality of lif…

  • Correlates of psychological intimate partner violence with HIV care outcomes on patients in HIV care

    Open Access•Rob Jay Fredericksen, Robin M Nance et al.•ARTICLE•BMC Public Health•2021

    Psychological IPV, even in the absence of physical or sexual IPV, appears to be associated with HIV care outcomes and should be included in IPV measures integrated into routine HIV care

  • Vaporized nicotine use among patients in HIV care who smoke tobacco

    Rob Jay Fredericksen, Emma Fitzsimmons et al.•ARTICLE•AIDS Care•2023

    Evidence suggests adverse health effects from vaporized nicotine (VN) use, such as electronic “e” cigarettes, and limited efficacy to aid tobacco cessation. People with HIV (PWH) smoke tobacco at higher rates than the general population, with greater morbidity, highlighting the necessity of effective tobacco cessation tools. PWH may be more vulnerable to adverse effects of VN. Using semi-structured 1:1 interviews, we examined health beliefs regar…

  • Clinical and Behavioral Outcomes for Transgender Women Engaged in HIV Care

    Open Access•Sari L Reisner, Bridget M Whitney et al.•ARTICLE•AIDS and Behavior•2023

  • Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas

    Open Access•Umed Ibragimov, Melvin D Livingston et al.•ARTICLE•AIDS and Behavior•2023

  • Correlates of Intimate Partner Violence, Including Psychological Partner Violence, in a Multisite U.S. Cohort of People in HIV Care

    Open Access•Rob Jay Fredericksen, L S Mixson et al.•ARTICLE•AIDS and Behavior•2024

  • Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era

    Jimmy Ma, Betty Luu et al.•ARTICLE•AIDS Care•2024

    Substance use in people with HIV (PWH) negatively impacts antiretroviral therapy (ART) adherence. However, less is known about this in the current treatment era and the impact of specific substances or severity of substance use. We examined the associations of alcohol, marijuana, and illicit drug use (methamphetamine/crystal, cocaine/crack, illicit opioids/heroin) and their severity of use with adherence using multivariable linear regression in a…

  • Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time among People with HIV in the Current Treatment Era

    Open Access•Jimmy Ma, Joseph Delaney et al.•ARTICLE•AIDS and Behavior•2024

  • Barriers to accessing medications for opioid use disorder among rural individuals

    Open Access•Anna M Morenz, Robin M Nance et al.•ARTICLE•International Journal of Drug…•2025

    Access barriers vary by MOUD type for rural individuals with OUD. Compared to sublingual buprenorphine, methadone access was hindered more by transportation difficulties, while injectable long-acting buprenorphine was hindered more by affordability and finding a doctor or program. These barriers highlight the need to de-regulate and expand locations for methadone access and prescribing, and to improve affordability and prescriber uptake of newer …

Medicine (17 works) · HIV/AIDS Research and Interventions (16 works) · Psychiatry (14 works) · HIV, Drug Use, Sexual Risk (11 works) · Family medicine (9 works) · Internal Medicine (9 works) · Environmental health (8 works) · Human immunodeficiency virus (HIV (8 works) · Public health (8 works) · Health psychology (7 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae